Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Electrophysiological characterization of a Cav3.2 calcium channel missense variant associated with epilepsy and hearing loss

RN. Stringer, L. Cmarko, GW. Zamponi, M. De Waard, N. Weiss

. 2023 ; 16 (1) : 68. [pub] 20230921

Language English Country England, Great Britain

Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc23016193

T-type calcium channelopathies encompass a group of human disorders either caused or exacerbated by mutations in the genes encoding different T-type calcium channels. Recently, a new heterozygous missense mutation in the CACNA1H gene that encodes the Cav3.2 T-type calcium channel was reported in a patient presenting with epilepsy and hearing loss-apparently the first CACNA1H mutation to be associated with a sensorineural hearing condition. This mutation leads to the substitution of an arginine at position 132 with a histidine (R132H) in the proximal extracellular end of the second transmembrane helix of Cav3.2. In this study, we report the electrophysiological characterization of this new variant using whole-cell patch clamp recordings in tsA-201 cells. Our data reveal minor gating alterations of the channel evidenced by a mild increase of the T-type current density and slower recovery from inactivation, as well as an enhanced sensitivity of the channel to external pH change. To what extend these biophysical changes and pH sensitivity alterations induced by the R132H mutation contribute to the observed pathogenicity remains an open question that will necessitate the analysis of additional CACNA1H variants associated with the same pathologies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016193
003      
CZ-PrNML
005      
20231026110227.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13041-023-01058-2 $2 doi
035    __
$a (PubMed)37735453
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Stringer, Robin N $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000208877670
245    10
$a Electrophysiological characterization of a Cav3.2 calcium channel missense variant associated with epilepsy and hearing loss / $c RN. Stringer, L. Cmarko, GW. Zamponi, M. De Waard, N. Weiss
520    9_
$a T-type calcium channelopathies encompass a group of human disorders either caused or exacerbated by mutations in the genes encoding different T-type calcium channels. Recently, a new heterozygous missense mutation in the CACNA1H gene that encodes the Cav3.2 T-type calcium channel was reported in a patient presenting with epilepsy and hearing loss-apparently the first CACNA1H mutation to be associated with a sensorineural hearing condition. This mutation leads to the substitution of an arginine at position 132 with a histidine (R132H) in the proximal extracellular end of the second transmembrane helix of Cav3.2. In this study, we report the electrophysiological characterization of this new variant using whole-cell patch clamp recordings in tsA-201 cells. Our data reveal minor gating alterations of the channel evidenced by a mild increase of the T-type current density and slower recovery from inactivation, as well as an enhanced sensitivity of the channel to external pH change. To what extend these biophysical changes and pH sensitivity alterations induced by the R132H mutation contribute to the observed pathogenicity remains an open question that will necessitate the analysis of additional CACNA1H variants associated with the same pathologies.
650    _2
$a lidé $7 D006801
650    _2
$a vápníkové kanály $7 D015220
650    12
$a epilepsie $x genetika $7 D004827
650    12
$a nedoslýchavost $7 D034381
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a missense mutace $x genetika $7 D020125
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Cmarko, Leos $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Nantes Université, CNRS, INSERM, l'Institut du Thorax, Nantes, France $1 https://orcid.org/0000000342722784
700    1_
$a Zamponi, Gerald W $u Department of Clinical Neurosciences, Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada $1 https://orcid.org/0000000206449066
700    1_
$a De Waard, Michel $u Nantes Université, CNRS, INSERM, l'Institut du Thorax, Nantes, France $1 https://orcid.org/0000000227829615
700    1_
$a Weiss, Norbert $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. nalweiss@gmail.com $1 https://orcid.org/0000000200401109
773    0_
$w MED00200637 $t Molecular brain $x 1756-6606 $g Roč. 16, č. 1 (2023), s. 68
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37735453 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110221 $b ABA008
999    __
$a ok $b bmc $g 1999988 $s 1202555
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 16 $c 1 $d 68 $e 20230921 $i 1756-6606 $m Molecular brain $n Mol Brain $x MED00200637
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Archiving options